Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Blue Earth Therapeutics Ltd
University Health Network, Toronto
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Pathos AI, Inc.
National Institutes of Health Clinical Center (CC)
K36 Therapeutics, Inc.
M.D. Anderson Cancer Center